Evidence map›Paper›PMID 35719943›Full record

ArticleFrontiers in oncology2022

Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer.

Li-Juan Gao, Jia-Lei Li, Rui-Rui Yang, Zhong-Mei He, Min Yan, Xia Cao, Ji-Min Cao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Many Faces of Oligoadenylate Synthetases.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  11. Role of OAS gene family in COVID-19 induced heart failure.Journal of translational medicine · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Li-Juan GaoKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Jia-Lei LiKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Rui-Rui YangKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Zhong-Mei HeKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Min YanKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Xia CaoKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Ji-Min CaoKey Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: OAS gene family plays an important role in antiviral process, but its role in pancreatic cancer has not yet been studied. Methods: We analyzed the expression, prognostic value and biological function of the OAS gene family in human pancreatic cancer through comprehensive bioinformatic analysis and cellular level validation. Results: OAS family was highly expressed in pancreatic cancer, and this high expression significantly affected the clinical stage and prognosis of the tumor. OAS gene family was closely related to the immune infiltration of pancreatic cancer, especially neutrophils and dendritic cells, and many immune-related factors and pathways are enriched in the tumor, such as type I interferon signaling pathway and NOD-like receptor signaling pathway. Conclusion: Taken together, high expression of OAS family is closely related to poor prognosis of pancreatic cancer. OAS gene family may serve as the biomarker and even therapeutic target of pancreatic cancer.

Indexed as

biomarkerimmune infiltrationOAS gene familypancreatic cancerprognosis

Identifiers

PMID35719943
PMCPMC9205247
OpenAlexW4281608287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.